AS-3334034

N/A

Report date: 2022/07/01 15:29:28

NME

Base Information

Drug NameAS-3334034

Drug Alias NameAS-3334034

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSerine/threonine-protein kinase RIPK2 inhibitors

TargetsSerine/threonine-protein kinase RIPK2

Therapy Area/IndicationsRenal Insufficiency, Chronic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAstellas Pharma Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsRenal Insufficiency, Chronic

Inactive IndicationsN/A

ATC CodeN/A